These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10780984)

  • 61. Systemic administration of kainate induces marked increases of endogenous kynurenate in various brain regions and plasma of rats.
    Baran H; Gramer M; Hönack D; Löscher W
    Adv Exp Med Biol; 1996; 398():265-6. PubMed ID: 8906275
    [No Abstract]   [Full Text] [Related]  

  • 62. Nerve cell death induced in vivo by kainic acid and quinolinic acid does not involve apoptosis.
    Ignatowicz E; Vezzani AM; Rizzi M; D'Incalci M
    Neuroreport; 1991 Nov; 2(11):651-4. PubMed ID: 1839770
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of kynurenines in the production of neuronal death, and the neuroprotective effect of purines.
    Stone TW; Behan WM; Jones PA; Darlington LG; Smith RA
    J Alzheimers Dis; 2001 Aug; 3(4):355-366. PubMed ID: 12214038
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kainic acid neurotoxicity in the goldfish optic tectum. No protection by the NMDA receptor antagonist MK801 and partial protection by abolition of a tectal excitatory input.
    Migani P
    Brain Res; 1994 Feb; 637(1-2):313-6. PubMed ID: 8180812
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Kynurenic acid antagonists and kynurenine pathway inhibitors.
    Stone TW
    Expert Opin Investig Drugs; 2001 Apr; 10(4):633-45. PubMed ID: 11281814
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ca2+-dependent kainate excitotoxicity in the chick embryonic neural retina ex vivo.
    Burgos JS; Barat A; Ramirez G
    Neuroreport; 2000 Nov; 11(17):3855-8. PubMed ID: 11117503
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 17Beta-estradiol attenuates quinolinic acid insult in the rat hippocampus.
    Heron P; Daya S
    Metab Brain Dis; 2001 Dec; 16(3-4):187-98. PubMed ID: 11769331
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Changes in cholesterol biosynthetic and transport pathways after excitotoxicity.
    Kim JH; Jittiwat J; Ong WY; Farooqui AA; Jenner AM
    J Neurochem; 2010 Jan; 112(1):34-41. PubMed ID: 19860851
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection.
    Stone TW
    Trends Pharmacol Sci; 2000 Apr; 21(4):149-54. PubMed ID: 10740291
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Metabolism and function of brain kynurenines.
    Schwarcz R
    Biochem Soc Trans; 1993 Feb; 21(1):77-82. PubMed ID: 8449358
    [No Abstract]   [Full Text] [Related]  

  • 71. Prevention by a purine analogue of kainate-induced neuropathology in rat hippocampus.
    MacGregor DG; Jones PA; Maxwell WL; Graham DI; Stone TW
    Brain Res; 1996 Jun; 725(1):115-20. PubMed ID: 8828594
    [TBL] [Abstract][Full Text] [Related]  

  • 72. (R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats.
    Speciale C; Wu HQ; Cini M; Marconi M; Varasi M; Schwarcz R
    Eur J Pharmacol; 1996 Nov; 315(3):263-7. PubMed ID: 8982663
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of in vivo sodium azide administration on the immunohistochemical localization of kynurenine aminotransferase in the rat brain.
    Knyihár-Csillik E; Okuno E; Vécsei L
    Neuroscience; 1999; 94(1):269-77. PubMed ID: 10613517
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.
    Stone TW
    Prog Neurobiol; 2001 Jun; 64(2):185-218. PubMed ID: 11240212
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ATP as a marker of excitotoxin-induced nerve cell death in vivo.
    Vezzani A; Sangalli L; Wu HQ; Schwarcz R
    J Neural Transm; 1987; 70(3-4):349-56. PubMed ID: 2960779
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus.
    Wu HQ; Lee SC; Schwarcz R
    Eur J Pharmacol; 2000 Mar; 390(3):267-74. PubMed ID: 10708733
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Basic mechanisms of kynurenine actions in the central nervous system.
    Stone TW; MacGregor DG; Smith RA; Jones P; Behan WM; Graham DI
    Adv Exp Med Biol; 1996; 398():195-201. PubMed ID: 8906266
    [No Abstract]   [Full Text] [Related]  

  • 78. Quinolinate and kainate facilitate magnesium penetration into brain tissue.
    Rothe F; Wolf G; Fischer S; Hass P; Keilhoff G; Abicht K
    Neuroreport; 1993 Feb; 4(2):205-7. PubMed ID: 8453060
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The kynurenines and the seizures.
    Guzeva VI; Mikhailov IB; Melnikova NV
    Adv Exp Med Biol; 1996; 398():263-4. PubMed ID: 8906274
    [No Abstract]   [Full Text] [Related]  

  • 80. The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatment.
    Müller N; Myint AM; Schwarz MJ
    Dialogues Clin Neurosci; 2009; 11(3):319-32. PubMed ID: 19877499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.